PAVmed to Present at the 16th Annual Needham Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017, at 10:20 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the company’s innovative business model and review PAVmed’s lead products. The conference is taking place at the Westin New York Grand Central Hotel in New York City on April 4th and 5th.

To access the live webcast of the presentation, please click here. A replay will be available following the presentation.

About PAVmed

PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding multi-product pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs, have attractive regulatory pathways and market opportunities and encompass a broad spectrum of clinical areas including carpal tunnel syndrome (CarpX™), medical infusions (NextFlo™ and NextCath™), interventional radiology (PortIO™ and NextCath), tissue ablation and cardiovascular intervention (Caldus™) and pediatric ear infections (DisappEAR™). The Company intends to further expand its pipeline through engagements with clinician innovators and leading academic medical centers. For further information, please visit www.pavmed.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170328005129/en/

Investors
LHA
Kim Sutton Golodetz, 212-838-3777
[email protected]
or
Media
RooneyPartners
Kate Barrette, 212-223-0561
[email protected]

Source: PAVmed Inc.

You May Also Be Interested In

• Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
• Subscription-Based Services Boom! Geek+ Reports 2026 Interim Results: Orders Up 35.5%, Breakthroughs Across the Business Spectrum
• KKR-Singtel Consortium Completes Acquisition of STTGDC; Company Launches Refreshed Global Brand for Next Phase of Growth